THE THERAPEUTIC EFFECT OF ALLOPURINOL IN FATTY LIVER DISEASE IN RATS

Area of Science:

• Hepatology
• Pharmacology
• Biochemistry

Background:

• Hyperuricemia is a known risk factor associated with non-alcoholic fatty liver disease (NAFLD).
• Understanding the therapeutic potential of managing hyperuricemia in NAFLD is crucial.

Purpose of the Study:

• To investigate the therapeutic effect of allopurinol on the progression of NAFLD in a rat model.
• To evaluate the impact of allopurinol on liver histopathology, inflammation, and oxidative stress markers.

Main Methods:

• A rat model of NAFLD was induced using fructose in drinking water.
• Animals were divided into control, allopurinol-treated, and placebo (saline) groups.
• Histopathological scores, IL-1 and IL-2 immunoexpression, xanthine oxidase activity, and lipid peroxidation were assessed.

Main Results:

• Allopurinol significantly reduced xanthine oxidase activity and lipid peroxidation compared to placebo.
• The allopurinol group exhibited significantly lower liver histopathological scores.
• Reduced immunoexpression of IL-1 and IL-2 was observed in the allopurinol-treated group.

Conclusions:

• Allopurinol demonstrates a therapeutic role in mitigating the progression of NAFLD in rats.
• Targeting hyperuricemia with allopurinol may be a viable strategy for NAFLD management.